Mats Ljungman

Mats Ljungman

University of Michigan

H-index: 62

North America-United States

About Mats Ljungman

Mats Ljungman, With an exceptional h-index of 62 and a recent h-index of 36 (since 2020), a distinguished researcher at University of Michigan,

His recent articles reflect a diverse array of research interests and contributions to the field:

KLIPP: Precision targeting of cancer with CRISPR

Epigenetic Reprogramming of Autophagy Drives Mutant IDH1 Glioma Progression and Response to Radiation

Abstract A001: Silencing of EYA4 regulates stemness in H3K27M-mutant diffuse midline glioma

Targeting DNA Repair and Survival Signaling in Diffuse Intrinsic Pontine Gliomas to Prevent Tumor Recurrence

Characterizing nascent transcription patterns of PROMPTs, eRNAs, and readthrough transcripts in the ENCODE4 deeply profiled cell lines

First-in-Class NADH/Ubiquinone Oxidoreductase Core Subunit S7 (NDUFS7) Antagonist for the Treatment of Pancreatic Cancer

Cdc73 protects Notch-induced T-cell leukemia cells from DNA damage and mitochondrial stress

GRHL2-controlled gene expression networks in luminal breast cancer

Mats Ljungman Information

University

Position

Radiation Oncology

Citations(all)

10800

Citations(since 2020)

4218

Cited By

8263

hIndex(all)

62

hIndex(since 2020)

36

i10Index(all)

136

i10Index(since 2020)

99

Email

University Profile Page

University of Michigan

Google Scholar

View Google Scholar Profile

Top articles of Mats Ljungman

Title

Journal

Author(s)

Publication Date

KLIPP: Precision targeting of cancer with CRISPR

Cancer Research

Mats Ljungman

Huibin Yang

Radhika Suhas Hulbatte

Natalie Gratsch

Alan Kelher

...

2024/3/22

Epigenetic Reprogramming of Autophagy Drives Mutant IDH1 Glioma Progression and Response to Radiation

NUNEZ FJ

K Banerjee

AA Mujeeb

A Mauser

CE Tronrud

...

2024/3/13

Abstract A001: Silencing of EYA4 regulates stemness in H3K27M-mutant diffuse midline glioma

Cancer Research

Ivana Barravecchia

Monika Sharma

Brian Magnuson

Sarah F Ferris

April Apfelbaum

...

2024/3/4

Targeting DNA Repair and Survival Signaling in Diffuse Intrinsic Pontine Gliomas to Prevent Tumor Recurrence

Molecular cancer therapeutics

Monika Sharma

Ivana Barravecchia

Robert Teis

Jeanette Cruz

Rachel Mumby

...

2024/1/3

Characterizing nascent transcription patterns of PROMPTs, eRNAs, and readthrough transcripts in the ENCODE4 deeply profiled cell lines

bioRxiv

Ariel McShane

Ishwarya Venkata Narayanan

Michelle T Paulsen

Mario Ashaka

Hailey Blinkiewicz

...

2024

First-in-Class NADH/Ubiquinone Oxidoreductase Core Subunit S7 (NDUFS7) Antagonist for the Treatment of Pancreatic Cancer

ACS Pharmacology & Translational Science

Yibin Xu

Ding Xue

Armita Kyani

Armand Bankhead III

Joyeeta Roy

...

2023/6/28

Cdc73 protects Notch-induced T-cell leukemia cells from DNA damage and mitochondrial stress

Blood

Ashley F Melnick

Carea Mullin

Karena Lin

Anna C McCarter

Shannon Liang

...

2023/12/21

GRHL2-controlled gene expression networks in luminal breast cancer

Cell Communication and Signaling

Zi Wang

Bircan Coban

Haoyu Wu

Jihed Chouaref

Lucia Daxinger

...

2023/1/23

The ENCODE4 long-read RNA-seq collection reveals distinct classes of transcript structure diversity

bioRxiv

Fairlie Reese

Brian Williams

Gabriela Balderrama-Gutierrez

Dana Wyman

Muhammed Hasan Çelik

...

2023/5/16

Abstract C150: Targeted inhibition of homologous recombination and nonhomologous end joining in diffuse intrinsic pontine gliomas to prevent tumor recurrence

Molecular Cancer Therapeutics

Ivana Barravecchia

Monika Sharma

Robert Teis

Jeanette Cruz

Rachel Mumby

...

2023/12/1

KLIPP-a precision CRISPR approach to target structural variant junctions in cancer

bioRxiv

Huibin Yang

Radhika Suhas Hulbatte

Alan Kellher

Natalie Gratsch

Yin Wang

...

2023/5/12

DDDR-05. TARGETED INHIBITION OF DNA REPAIR AND SURVIVAL SIGNALING IN DIFFUSE INTRINSIC PONTINE GLIOMAS

Neuro-Oncology

Ivana Barravecchia

Monika Sharma

Robert Teis

Jeanette Cruz

Rachel Mumby

...

2023/11/1

Zinc Finger MYND-Type Containing 8 (ZMYND8) is epigenetically regulated in mutant Isocitrate Dehydrogenase 1 (IDH1) glioma to promote radioresistance

Clinical Cancer Research

Stephen V Carney

Kaushik Banerjee

Anzar Mujeeb

Brandon Zhu

Santiago Haase

...

2023/5/1

Histone H3 K27M-mediated regulation of cancer cell stemness and differentiation in diffuse midline glioma

Neoplasia

Monika Sharma

Ivana Barravecchia

Brian Magnuson

Sarah F Ferris

April Apfelbaum

...

2023/10/1

A precision CRISPR approach to target structural variant junctions in cancer

Cancer Research

Radhika Suhas Hulbatte

Huibin Yang

Natalie Gratsch

Alan Kellher

Phillip L Palmbos

...

2023/4/4

KMT2D links TGF‐β signaling to noncanonical activin pathway and regulates pancreatic cancer cell plasticity

International Journal of Cancer

Shuang Lu

Hong Sun Kim

Yubo Cao

Karan Bedi

Lili Zhao

...

2023/8/1

miRNA analysis reveals novel dysregulated pathways in amyotrophic lateral sclerosis

Human Molecular Genetics

Junguk Hur

Ximena Paez-Colasante

Claudia Figueroa-Romero

Ting-wen Lo

Sami J Barmada

...

2023/3/15

EWS:: FLI1 and HOXD13 control tumor cell plasticity in Ewing sarcoma

Clinical Cancer Research

April A Apfelbaum

Feinan Wu

Allegra G Hawkins

Brian Magnuson

Jennifer A Jiménez

...

2022/10/14

KDM6A regulates cell plasticity and pancreatic cancer progression by noncanonical activin pathway

Cellular and molecular gastroenterology and hepatology

Zhujun Yi

Shanqiao Wei

Lin Jin

Sivakumar Jeyarajan

Jing Yang

...

2022/1/1

Transcription and genome integrity

DNA repair

Mats Ljungman

2022/10/1

See List of Professors in Mats Ljungman University(University of Michigan)